Home > Insider Trading > Biohaven Ltd. > Profile

Biohaven Ltd. (BHVN)

Market is closed

Get Email Alerts

Profile
Hedge Fund Holdings
Insider Purchases
Insider Sales
Institutional Holdings
13 D/G Filings
News

Get Email Alerts

Related Insiders

W John Childs, Director, 2025-03-05
Bruce Car, Chief Scientific Officer, 2025-01-08
Kimberly Gentile, Svp, Clinical Operations, 2025-01-08

W John Childs, Director, 2025-03-05
Bruce Car, Chief Scientific Officer, 2025-01-08
Kimberly Gentile, Svp, Clinical Operations, 2025-01-08
C. George Clark, Vp, Chief Accounting Officer, 2025-01-08
Matthew Buten, Chief Financial Officer, 2025-01-08
Vlad Coric, Chief Executive Officer, 2025-01-08
Gregory Bailey, Director, 2024-09-25
Kishan Mehta, , 2024-05-02
Thomas Michael Heffernan, , 2024-05-02
P Julia Gregory, , 2024-05-02
J Robert Hugin, , 2024-05-02
Irina Antonijevic, , 2024-05-02
Biohaven Pharmaceutical Holding Co Ltd., , 2022-10-05

Show All Insiders (13)

Insider Trading: Purchases See All

Insider	Price	Amount	Relationship	Remaining Holdings	Date	Form 4
Childs	$30.73	900	Director	25,291	2025-03-04	Filing
Childs	$30.73	3,400	Director	76,570	2025-03-04	Filing
Childs	$30.73	3,400	Director	24,452	2025-03-04	Filing
Childs	$30.39	25,000	Director	2,320,571	2025-03-04	Filing
Childs	$41.00	73,170	Director	73,170	2024-04-22	Filing

Insider Trading: Sales See All

Insider	Price	Amount	Relationship	Remaining Holdings	Date	Form 4
Antonijevic	$41.79	11,000		2,535	2023-12-29	Filing

News See All

Jim Cramer Recently Talked About These 15 Stocks

On Tuesday, Jim Cramer, host of Mad Money, offered his perspective on the day’s market rally as he delved into the impact of the ongoing dynamic between President Donald Trump and Federal Reserve Chair...

Keep Reading →

April 23rd, 2025 - Hedge Funds News

11 Best Guru Stocks to Buy According to Wall Street Analysts

Wall Street seems to be breathing a little easier after the initial panic over President Trump’s tariffs earlier this month, but the rollercoaster is not over just yet.

Keep Reading →

April 21st, 2025 - Hedge Funds News

12 Stocks with Heavy Insider Buying in 2025

Insider trading is often seen as an important indicator of management’s confidence in their company’s future.

Keep Reading →

March 7th, 2025 - Hedge Funds News

Why Biohaven (BHVN) Stock Is Rallying Today

The FDA agreed to review BHVN's application for the approval of its drug candidate, troriluzole, Biohaven announced today. Additionally, the agency decided to grant the drug Priority Review status.

Keep Reading →

February 11th, 2025 - Market Movers News